Epstein-barr Virus-associated Leiomyosarcoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2025-02-24
Clinical Trial Update: Nanatinostat Plus Valganciclovir in Advanced EBV+ Solid Tumors and in Combination With Pembrolizumab in EBV+ RM-NPC [Phase 1]
Phase 1 clinical trial evaluating Nanatinostat with valganciclovir (and in combination with pembrolizumab) for EBV-positive solid tumors, in…